SLC2A1 and colorectal carcinoma: Additionally, IGF2BP2 stabilizes hexokinase 2 (HK2), and both IGF2BP2 and IGF2BP3 stabilize solute carrier family 2 member 1 (SLC2A1, GLUT1), which activate glycolysis to promote CRC progression [98].